Merck to acquire biotech company Prometheus Biosciences for $10.8bn

Pallavi Madhiraju- April 16, 2023 0

Merck has agreed to acquire Prometheus Biosciences, a Nasdaq-listed clinical-stage biotechnology company, in an all-cash deal worth around $10.8 billion, in a move to bolster ... Read More

Eris Lifesciences strikes deal for Dr. Reddy’s cosmetic dermatology brands

Pallavi Madhiraju- March 18, 2023 0

Eris Lifesciences has announced the acquisition of nine cosmetic dermatology brands in the Indian market from Dr. Reddy's Laboratories for INR 275 crores in cash. ... Read More

Pfizer to acquire cancer drugmaker Seagen for $43bn in cash

Raghuram Kadari- March 16, 2023 0

American pharmaceutical and biotechnology company Pfizer has agreed to acquire cancer drugmaker Seagen (formerly Seattle Genetics) for $229 per share or $43 billion in cash, ... Read More

Sesen Bio gets shareholders’ approval for merger with Carisma Therapeutics

Pallavi Madhiraju- March 4, 2023 0

Nasdaq-listed Sesen Bio said that its stockholders have approved the previously announced merger deal with Carisma Therapeutics aimed at creating a clinical-stage biotechnology company for ... Read More

Dr. Reddy’s Laboratories to acquire Mayne Pharma’s US retail generics portfolio

Pallavi Madhiraju- February 28, 2023 0

Dr. Reddy's Laboratories has agreed to acquire the US generic prescription product portfolio of Mayne Pharma Group, an Australian pharma company, in a deal worth ... Read More

AstraZeneca wraps up $1.8bn acquisition of CinCor Pharma

Raghuram Kadari- February 28, 2023 0

AstraZeneca has closed the previously announced $1.8 billion acquisition of US biopharmaceutical company CinCor Pharma. Under the terms of the agreement, AstraZeneca acquired all outstanding ... Read More

Clinical-stage Redx Pharma, Jounce Therapeutics sign $425m merger deal

Pallavi Madhiraju- February 23, 2023 0

Redx Pharma, a UK-based clinical-stage biotechnology company, and Jounce Therapeutics, a Nasdaq-listed clinical-stage immunotherapy company, have agreed to merge in an all-stock deal that values ... Read More

Sol-Gel acquires Gorlin syndrome drug candidate Patidegib from PellePharm

Raghuram Kadari- January 31, 2023 0

Sol-Gel Technologies, an Israel-based dermatology company, has acquired patidegib, a Gorlin syndrome drug candidate in phase 3 development, from US-based biotechnology company PellePharm, in a ... Read More

Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise

Raghuram Kadari- January 20, 2023 0

India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More

AstraZeneca closes acquisition of cell therapy company Neogene Therapeutics

Pallavi Madhiraju- January 17, 2023 0

Pharma giant AstraZeneca has closed the previously announced acquisition of Neogene Therapeutics, a US-based clinical-stage biotechnology company. Neogene Therapeutics is engaged in the discovery, development, ... Read More